Helen M. Thackray Immuno Gen, Inc. (IMGN) insider trading activity

IMGN Quotes by TradingView

Helen M. Thackray is Director of ImmunoGen, Inc.. Currently has a direct ownership of 0 shares of IMGN, which is worth approximately $0. The most recent transaction as insider was on Feb 12, 2024, when has been sold 3,074 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0
0% 3M change
100.0% 12M change
Total Value Held $0

Helen M. Thackray Transaction History

Date Transaction Value Shares Traded Shares Held Form
Feb 12 2024
SELL
Sale (or disposition) back to the issuer
-
3,074 Reduced 100.0%
0 Common Stock
Dec 29 2023
BUY
Grant, award, or other acquisition
$7,471 $29.65 p/Share
252 Added 7.58%
3,074 Common Stock
Sep 29 2023
BUY
Grant, award, or other acquisition
$7,490 $15.87 p/Share
472 Added 14.33%
2,822 Common Stock
Jun 30 2023
BUY
Grant, award, or other acquisition
$7,491 $18.87 p/Share
397 Added 14.45%
2,350 Common Stock
Mar 31 2023
BUY
Grant, award, or other acquisition
$7,499 $3.84 p/Share
1,953 Added 50.0%
1,953 Common Stock

Also insider at

GLYC
GLYCOMIMETICS INC Healthcare
SVP Clinical Development, CMO
BCRX
BIOCRYST PHARMACEUTICALS INC Healthcare
Chief R&D Officer
HMT

Helen M. Thackray

Director
Durham, NC

Track Institutional and Insider Activities on IMGN

Follow ImmunoGen, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells IMGN shares.

Notify only if

Insider Trading

Get notified when an Immuno Gen, Inc. insider buys or sells IMGN shares.

Notify only if

News

Receive news related to ImmunoGen, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on IMGN